Speed. Accuracy. Zero Boundaries
From urgent care to field clinics, diagnostics are inconsistent and offline.
We need a deployable platform that delivers lab-grade panels and integrates results into EMRs in real time.
70%
of medical decisions depend on lab tests
27%
failure rate for labs with leading point-of-care system
30%
lower healthcare costs with timely accurate tests, leading POC is cost prohibitive
20
year-old technology underlies the leading point-of-care system
4°C
Short shelf life and refrigeration needs hinder storage and deployment
Reliability in Every Condition
Nanost’s heat-stable nanobodies maintain binding affinity in high-temperature, low-resource environments—reducing cold-chain dependency and improving reliability where it's needed most.
Streamlined Innovation
Nanost’s nanobodies are produced in microbial expression systems like yeast or E. coli—enabling scalable, cost-effective manufacturing that supports low-cost diagnostic deployment.
Precision Redefined
Nanobodies offer greater stability and shelf life than traditional antibodies—up to 10X in lateral flow and microfluidic formats. This enables consistent performance in point-of-care and field-based settings.
Targeted Efficiency
Designed for high specificity, Nanost’s nanobodies target clinically relevant proteins with minimal off-target binding—improving signal clarity and diagnostic confidence.
Reduced Immunogenicity
Nanost’s nanobodies are engineered to minimize nonspecific binding and immune interference—reducing false positives caused by heterophilic antibodies and improving result reliability across diverse patient populations.
